Please login to the form below

Not currently logged in

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Pfizer finally acquires the @pfizer name on Twitter

Will streamline its existing @pfizer_news account

Pfizer Twitter

Four years after making its debut on Twitter Pfizer has taken control of its brand on the social network and started using the @pfizer account.

The company, currently the world's largest pharmaceutical firm, was too late to claim an account in its own name when it first joined Twitter and was forced to settle for using @pfizer_news.

Pfizer confirmed yesterday it has now “acquired” its brand name account, but at the time of writing has yet to respond to questions about how this came about - whether by buying the name from its previous holder, appealing to Twitter or some other route.

In a statement the company said: “The @pfizer handle wasn't available when Pfizer first joined Twitter in 2009. We didn't want to delay our entry into social media, so we decided to choose an alternate handle for our launch: @pfizer_news.

“Many of you already write @pfizer in your mentions and messages (even before we had the name), so it feels right to swap in @pfizer to replace @pfizer_news as the new name of our primary feed.”

Pfizer said its content won't be change but “our Twitter handle will just more accurately reflect the scope of what we're sharing”.

The company's long-term plan is for the @pfizer_news account to remain active, but be relaunched as a 'streamlined feed' that will only feature the company's press releases.

Pfizer's main account on Twitter has more than 56,000 followers, who will now find they are following @pfizer – people that still want to follow the news account will need to re-follow @pfizer_news.

Meanwhile Pfizer said @pfizer will have a wider remit than the news account, covering topics such as public policy, though to date there is little difference between the two.

13th November 2013

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Black Swan Analysis

We are experts in pharmaceutical forecasting with access to proprietary databases of disease-specific patient populations. We understand the limits of...

Latest intelligence

Access to orphan drugs for rare cancers in EU28
Revisiting Instagram for pharma
In pharma, Instagram usage is increasing because it offers so many benefits to engage with patients and HCPs...
The one multichannel question you must ask
There is a question every marketer should ask when designing a multichannel communications strategy...